Mauna Kea Technologies SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Mauna Kea Technologies SAS Issues FY 2013 Revenue Guidance
Mauna Kea Technologies SAS announced that it expects to report for full year 2013 strong sales growth momentum. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of EUR 19.25 million for full year 2013.
Latest Developments for Mauna Kea Technologies SA
- Mauna Kea Technologies announces results of Cellvizio study with pancreatic cysts
- Mauna Kea Technologies says French National Authority for Health approves optical endomicroscopy review
- Mauna Kea Technologies SA regulatory clearance from U.S. FDA for New Cellvizio System Functioning in a near Infrared Wavelength
- Mauna Kea Technologies receives regulatory approval for Cellvizio in Japan
Latest Key Developments in Advanced
- Hamilton Thorne announces private placement unit offering of up to C$750,000
- Accelera Innovations Inc announces purchase agreement of SCI Home Health Inc
- Varian Medical Systems Inc gives Q1, FY 2015 EPS guidance below analysts' estimates
- Nanosphere Inc prices $20 million public offering of common stock
- Share this
- Digg this